Future of clinical trials: COVID-19 accelerates shift to direct-to-patient model
FierceBiotech
Alex Guite, Vice President, Services and Alliances at World Courier, and Kim McLeod, Director of Prospective Clinical Research at Xcenda, spoke with Rebecca Willumson and Fierce Biotech about how the COVID-19 pandemic has disrupted clinical trials, accelerating a natural shift towards more direct-to-patient services. Watch the interview here.